Meyer Handelman Company’s Vertex Pharmaceuticals VRTX Stock Holding History

Meyer Handelman Company’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$342K	Buy	655 +80	+14%	+$41K	0.01%	206
2026 Q2	$286K	Hold	575	–	–	0.01%	216
2026 Q1	$257K	Hold	575	–	–	0.01%	201
2025 Q4	$261K	Buy	+575	New	+$248K	0.01%	201
2024 Q4	–	Sell	-575	Closed	-$267K	–	218
2024 Q3	$267K	Hold	575	–	–	0.01%	192
2024 Q2	$270K	Hold	575	–	–	0.01%	190
2024 Q1	$240K	Hold	575	–	–	0.01%	192
2023 Q4	$234K	Buy	+575	New	+$212K	0.01%	182
2023 Q3	–	Sell	-575	Closed	-$202K	–	197
2023 Q2	$202K	Buy	+575	New	+$194K	0.01%	182

Other funds holding VRTX

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Meyer Handelman Company's VRTX Position: Q3 2026 in Review

Meyer Handelman Company increased its Vertex Pharmaceuticals (VRTX) stake by 14% in Q3 2026, buying an estimated $41K and bringing the position to 655 shares worth $342K. The position accounts for 0.01% of the portfolio, ranked #206.

Meyer Handelman Company first reported a position in VRTX in Q2 2023 and has held it in 9 quarters since. 1,556 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

Meyer Handelman Company held 655 shares of Vertex Pharmaceuticals worth $342K as of Q3 2026.
Meyer Handelman Company bought 80 Vertex Pharmaceuticals shares in Q3 2026, an estimated $41K.
Vertex Pharmaceuticals made up 0.01% of Meyer Handelman Company's portfolio in Q3 2026, its #206 holding.
Meyer Handelman Company first reported a position in Vertex Pharmaceuticals in Q2 2023 and has held it in 9 quarters since.
1,556 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Meyer Handelman Company's 13F filing for Q3 2026, filed 28 Oct 2026.